Skip to content

Total Revenue at other companies

Eli Lilly logo
Eli LillyLLY
$19.8B+55.5%
Sarepta Therapeutics, Inc. logo
Sarepta Therapeutics, Inc.SRPT
$730.8M-1.9%
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
$246.09M+87.0%
Madrigal Pharmaceuticals, Inc. logo
Madrigal Pharmaceuticals, Inc.MDGL
$311.34M+127%
ALN
Alnylam PharmaceuticalsALNY
$1.17B+96.4%
Beam Therapeutics logo
Beam TherapeuticsBEAM
$31.74M+325%

Other financials

Income statement

See full
Operating income-$31.3M+37.2%
Net income-$26.1M+44.4%
EPS (diluted)-$0.13+55.2%

Balance sheet

See full
Cash & equivalents$544.6M+124%
Total debt$15.7M-33.4%
Total equity$511.7M+198%
Total assets$583.5M+102%

Cash flow

See full
Operating cash flow-$59.6M+5.5%
CapEx$438.0K+165%
Free cash flow-$60.0M+5.1%

Valuation

See full
Market cap$1.14B+10.1%
Enterprise value$615.92M-18.1%
P/S15.1×-12.2×

Profitability

See full
Operating margin-75.7%-33.6pp
Net margin-66.5%-29.9pp
FCF margin-27.2%-12.6pp

Returns & leverage

See full
Return on equity-53.7%
Debt / equity-0.1×
Current ratio11.3×+8.3×

Where this comes from

Reported directly by Wave Life Sciences in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Wave Life Sciences’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Wave Life Sciences's total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Wave Life Sciences's total revenue?
Wave Life Sciences (WVE) reported total revenue of $38.25M in Q1 2026.
How has Wave Life Sciences's total revenue changed year-over-year?
Wave Life Sciences's total revenue increased by 316.9% year-over-year, from $9.18M to $38.25M.
What is the long-term trend for Wave Life Sciences's total revenue?
Over 2 years (2021 to 2023), Wave Life Sciences's total revenue has grown at a 66.3% compound annual growth rate (CAGR), from $40.96M to $113.31M.
What does total revenue mean?
The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.